Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial.

Ian BoostromYohan BalaJelena Minic VasicJelena GluvakovEmmanuel ChanardAndrew H BarrattKirsty SandsEdward PortalLaurence DevigneLucy C JonesOwen Brad Spiller

Published in: The Journal of antimicrobial chemotherapy (2021)

The redesigned MYCOPLASMA IST3 assay eliminated previous shortcomings by providing independent accurate resistance screening of M. hominis and Ureaplasma species, even in mixed infections, with CLSI-compliant thresholds. Specificity, sensitivity and enumeration estimates correlated closely with the confirmatory methods.

Keyphrases

respiratory tract
high throughput
study protocol
clinical trial
circulating tumor cells
randomized controlled trial
phase iii
phase ii
high resolution
double blind
single cell
genetic diversity